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Protein synthesis in rabbit reticulocytes: Mechanism of protein
synthesis inhibition by heme-regulated inhibitor*
(translational regulation/Met-tRNAf binding factor/eukaryotic initiation factors/protein phosphorylation)

A. DAS, R. 0. RALSTON, M. GRACE, R. Roy, P. GHOSH-DASTIDAR, H. K. DAS, B. YAGHMAI,
S. PALMIERI, AND N. K. GUPTA
Department of Chemistry, University of Nebraska, Lincoln, Nebraska 68588

Communicated by Myron K. Brakke, July 27,1979

Partially purified Met-tRNAf binding factor,
ABSTRACT
eIF-2, was phosphorylated by using heme-regulated inhibitor
(HRI). Phosphorylated eIF-2 was freed from HRI by phosphocellulose column chromatography. Analysis by isoelectric focusing showed 100% phosphorylation of the 38,000-dalton
subunit of eIF-2. Both eIF-2 and eIF-2(P) formed ternary complexes with Met-tRNAf and GTP with almost the same efficiency, and in both cases the ternary complex formation was
drastically inhibited by prior addition of Mg2+. However,
whereas the ternary complexes formed with eIF-2 could be
stimulated by Co-eIF-2C at 1 mM Mg2+ and dissociated by
Co-eIF-2B at 5 mM Mg2+, the ternary complexes formed with
eIF-2(P) were unresponsive to both Co-eIF-2B and Co-eIF-2C.
Also under conditions of eIF-2 phosphorylation, HRI drastically
inhibited AUG-dependent Met-tRNAf binding to 40S ribosomes.
However, HRI (in the presence of ATP) had no effect on the
joining of preformed Met-tRNAfr40S-AUG complex to the 60S
ribosomal subunit to form Met-tRNAfr80S*AUG complex. These
studies suggest that HRI inhibits protein synthesis initiation by
phosphorylation of the 38,000-dalton subunit of eIF-2. HRIphosphorylated eIF-2 does not interact with at least two other
protein factors, Co-eIF-2B and Co-eIF-2C, and is thus inactive
in protein synthesis initiation.

peptide chain initiation and the precise role of HRI-phosphorylated eIF-2 in this inhibition process, we prepared eIF2(P) by using purified HRI and studied its interaction with
Co-eIF-2B and Co-eIF-2C. Our results clearly establish that
eIF-2(P) does not interact with Co-eIF-2B and Co-eIF-2C and
that phosphorylation of other component(s) is not involved in
this loss of interaction. Also, we report that HRI and ATP
strongly inhibit Met-tRNAf-40S-AUG complex formation but
do not have any effect on subsequent joining of preformed
Met-tRNAf.40S.AUG complex with the 60S ribosomal subunit
to form 80S initiation complex. These results thus suggest that
inhibition of protein synthesis initiation by HRI is entirely due
to phosphorylaton of eIF-2 and subsequent loss of interaction
of eIF-2(P) with other initiation factors.
MATERIALS AND METHODS
Materials. The materials were obtained from the following
sources: [35S]methionine [900 Ci/mmol (1 Ci = 3.7 X 1010
becquerels)] from Amersham/Searle; AUG from Miles Laboratories; phosphocellulose (P-li) from Whatman. [35S]Methionine was diluted with unlabeled methionine to 10,000-20,000
cpm/pmol.
Initiation Factors, HRI, and Ribosomal Subunits. The
peptide chain initiation factors eIF-2 and Co-eIF-2C were
prepared from reticulocyte ribosomal salt (0.5 M KCl) wash.
The crude ribosomal salt wash was further purified by using
DEAE-cellulose chromatography and ammonium sulfate
precipitation (fraction II) as described (22). The dialyzed
fraction II preparation was then passed through a phosphocellulose column equilibrated with buffer A [20 mM Tris-HCI,
pH 7.8/1 mM dithiothreitol/50 ,M EDTA/10% (vol/vol)
glycerol] containing 0.1 M KCl. The eIF-2 and Co-eIF-2C activities were adsorbed onto the column and were eluted by
washing the column with buffer A containing 0.65 M KCl. The
proteins were concentrated by ammonium sulfate (0-80%
saturation) precipitation. The precipitate was dissolved in a
minimal volume of buffer A containing 0.18 M KCI and the
solution was dialyzed for 6-8 hr against the same buffer with
one change. The dialyzed solution was then adsorbed onto a
CM-Sephadex C-50 column previously equilibrated with buffer
A containing 0.18 M KCl. Under these conditions, Co-eIF-2C

During heme deficiency, protein synthesis in reticulocyte lysates is inhibited due to activation of a latent protein synthesis
inhibitor, heme-regulated inhibitor (HRI) (7-9). HRI is a protein kinase that specifically phosphorylates the 38,000-dalton
subunit of Met-tRNAf binding factor, eIF-2 (10-14). HRI also
inhibits the following partial initiation reactions and in each
case, the inhibition requires ATP: (i) Co-eIF-2B-promoted
dissociation of Met-tRNAf-eIF-2-GTP complex at high Mg2+
and low temperature (0°C) (TDF activity) (3, 15, 16); (fi) CoeIF-2C stimulation of ternary complex formation at 1 mM
Mg2+ (5, 16-18); and (iii) Met-tRNAf binding to 40S ribosomes
(15, 16, 19). Based on these results, it has been proposed that
HRI phosphorylation causes conformational modification of
eIF-2 and that phosphorylated eIF-2 [eIF-2(P)] does not interact
with two factors, Co-eIF-2B and Co-eIF-2C, and is inactive in
peptide chain intiation. However, these studies do not conclusively establish the precise role of eIF-2(P) in the inhibition
process and the possibility that the phosphorylation of other
components such as HRI, Co-eIF-2B, and Co-eIF-2C also is
involved in this inhibition has not been ruled out. Moreover,
Trachsel and Staehelin (20) used prephosphorylated eIF-2 (HRI
catalyzed) and observed that both eIF-2(P) and eIF-2 were
equally active in all the partial initiation reactions studied including Met-tRNAf binding to 40S ribosomes. Also, the possibility that HRI can inhibit more than one step in peptide chain
initiation has been indicated (21).
To clearly establish the mechanism of HRI inhibition of

Abbreviations: The present nomenclature for the peptide chain initiation factors and their past nomenclature (shown in parenthesis) (1)
as once used by our laboratory are: eIF-2 (EIF-1), Met-tRNAf binding
factor (2, 3); eIF-2(P), phosphorylated eIF-2 (HRI catalyzed); CoeIF-2A (Co-EIF-1), a factor stimulating Met-tRNAf binding to eIF-2
(4); Co-eIF-2B (EIF-2, TDF), a factor promoting dissociation of ternary
complex at high Mg2+ (3); Co-eIF-2C (EIF-2B), a factor reversing
Mg2+ inhibition of ternary complex formation (5). HRI, heme-regulated translational inhibitor.
* This paper is no. 24 of a series. The previous paper in this series is ref.
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activity is not adsorbed onto the column and is eluted with the
0.18 M KCI wash of the column (17). The
s
The
concentrated by using ammonium sulfate
concentrated fraction was applied to a DEAE-cellulose column
previously equilibrated with buffer A. The column was washed
thoroughly with buffer A containing 0.1 M KCl. The adsorbed
protein was eluted by using a linear KC1 gradient (0.1-0.3 M
KCI) in buffer A. The active fractions were pooled and concentrated by using another DEAF-cellulose column and onestep elution with buffer A containing 0.3 M KCI.
The eIF-2 activity was eluted from the CM-Sephadex column
by using buffer A containing 0.4 M KCI. The active fractions
were pooled, and the pooled fraction was diluted 1:4 with buffer
A and was concentrated by passage through a small DEAEcellulose column equilibrated with buffer A containing 0.1 M
KCI and then one-step elution by using buffer A containing 0.3
M KC1.
Purification of Co-eIF-2A (4) and Co-eIF-2B (3) was as described. In some experiments, a partially purified initiation
factor preparation, fraction 11 (23), was used.
Preparation of HRI and ribosomal subunits was as before (15,

columtimiiw
precipitation.

23).

Preparation of eIF-2(P) A partially purified preparation of
eIF-2 [CM-Sephadex purified preparation; specific activity,
1200-1500(22)] was phosphorylated by using HRI. The reaction mixture (total volume, 0.8 ml) contained the following
10 mM
components: 20 mM Tris-HC1 at pH 7.8, 100mMofKCI,
MgCI2, 1 mM ATP, 2 mM dithiothreitol, 100 tig eIF-2, and
30 of HRI. The reaction mixture was incubated at 37 0C for
3tg
10 min and then was cooled in ice and applied to a small
phosphocellulose column (bed volume, 1 ml) previously
equilibrated with buffer A containing 0.3 M The column
activity was
was thoroughly washed with the same buffer.
eluted from the column by using buffer A containing 0.65 M
fractions were
KCI. The protein concentrations of the active
determined by the procedure of
et al. (24) and the
fractions were then mixed with bovine serum albumin (1

KCI.
eIF-2
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ergy-regenerating systems such as creatine phosphate plus
ctreatitae kinase and observed some stimulation (10-15%) of
ternary complex formation. However, the characteristics of
cofactor stimulation of eIF-2 activity were unchanged by such
additions. The cofactor stimulation of eIF-2 activity reported
in this paper is not due to reversal of GDP inhibition of ternary
complex formation (26).
Isoelectric Focusing. Isoelectric focusing in polyacrylamide
(27)
gels was performed according to the method of O'Farrell
as modified by Farrell et aL. (28). The gels were stained by using
the procedure described (29) for sodium dodecyl sulfate

gels.

RESULTS
eIF-2
was
phosphorylated by using HRI and
Partially purified
ATP, and the eIF-2(P) thus formed was further purified by
phosphocellulose chromatography. Under the experimental
conditions, HRI did not adsorb onto the column and was eluted
with the wash buffer. eIF-2(P) was eluted by washing the column with high-salt solution.
The extent of phosphorylation of eIF-2 was analyzed by
isoelectric focusing. Almost complete phosphorylation of the
38,000-dalton subunit of eIF-2 was observed (Fig. 1). The
control experiment, without HRI, showed no phosphorylation
of the 38,000-dalton subunit of eIF-2.
We compared the activities of eIF-2 and eIF-2(P) in different
partial initiation reactions. Both eIF-2 and eIF-2(P) formed
ternary complexes with almost equal efficiency, and in both
cases the complex formation was dependent on the presence
of GTP (Fig. 2). Also, both eIF-2 and eIF-2(P) responded sim(Table 1); Co-eIF-2A
ilarly to addition of Co-eIF-2A and
stimulated ternary complex formation by both eIF-2 and
inhibited ternary
eIF-2(P) (Exp. 1), and prior addition of
with
No significant
formation
both
factors
3).
(Exp.
complex

MMg2
Mg2+

Lowry

in the
mg/ml) and stored in ice. The amounts of eIF-2 addedprotein
experiment were calculated based on the original
bovine serum

Basic
Or

B..

rE

concentration of the solution before mixing with

albumin.

In the control experiment, the same amount of eIF-2 was
treated identically except that HRI was omitted from the incubation mixture. eIF-2 activity was similarly purified by
passage through an identical phosphocellulose column. This
eIF-2 preparation was used as control nonphosphorylated eIF-2
in all the experiments.
Millipore Filtration Assays for Peptide Chain Initiation
Factors. eIF-2 was assayed by using a Millipore filtration assay
formethod for ternary complex
mation as described (22, 25). The cofactors Co-eIF-2A,
eIF-2B, and Co-eIF-2C were added as indicated. The reaction
mixtures (total volume, 0.075 ml) contained: 20 mM
at pH 7.8; 100 mM
2 mM dithiothreitol; 0.26 mM GTP;
of bovine serum albumin; 8-10 pmol of
eIF-2; and where indicated, Co-eIF-2A,
and magnesium acetate. The reaction mixtures were incubated
at
for 5 min. At the end of incubation, 3 ml of cold wash
was added to
buffer (20 mM
pH 7.8/100mM
then filtered
the
reaction.
The
reaction
mixtures
were
stop
washed twice with
through Millipore filters. The filters wereradioactivity.
the same buffer, dried, and assayed for
out in two
In some experiments, the reactions were

10,ug
37°C

KCI;

Tris-HCl,

[35SJMet-tRNAf eIF-2.GTPCoTris-HCl

[s5S]MetAtRNAf;
Co-eIF-2C,
Co-eIF-2B,
KCI)

carried
procedures are

or more stages. Details of the experimental
described in the legends.
In several Millipore filtration experiments,

we

used

en-

F~~~~~~~~~~~~~~

r
E_

a:

re.
[:S
i:t.*

I.

L,~
.

~

4P

E:
r

eiF-2

*,,rF .
fib; e.

_bB
.!

\

elF-2c(P)

i:.

A.

Acidic
4
1
3
2
FIG. 1. Isoelectric focusing of eIF-2 and eIF-2(P). Lanes: 1 and
a
2, eIF-2, 1 and 1.4 Mg; 3 and 4, eIF-2(P), 1.4 and 2 Mg,
denotes the 38,000-dalton subunit of eIF-2. The large smeared band
at the top of the gel is due to bovine serum albumin in the preparations.
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spectively.

difference in Co-eIF-2A stimulation of ternary complex formation by eIF-2 or eIF-2(P) was observed when varying concentrations of Co-eIF-2A were used in these experiments.
However, whereas the ternary complexes formed with eIF-2
could be dissociated by Co-eIF-2B at 5 mM Mg2+ and low
temperature (TDF activity) (Exp. 2) and also could be stimulated by Co-eIF-2C at 1 mM Mg2+ (Exp. 3), the ternary complex formed with eIF-2(P) was not significantly affected by
addition of Co-eIF-2B or Co-eIF-2C under similar experimental
conditions. The effect of addition of different concentrations
of Co-eIF-2C on ternary complex formation by eIF-2 and
eIF-2(P) in the presence and absence of HRI is shown in Fig.

3. As expected, Co-eIF-2C stimulated ternary complex formation by eIF-2 and this stimulation was abolished by HRI in
the presence of ATP. Under similar experimental conditions,
formation of ternary complex with eIF-2(P) was neither stimulated by Co-eIF-2C nor inhibited by HRI.
The above experiments were done with eIF-2 and prephosphorylated eIF-2 and no further additions of HRI and ATP
were made during incubation. The results thus clearly establish
that eIF-2(P) did not interact with Co-eIF-2B or Co-eIF-2C and
no further phosphorylation of any other component or continued presence of HRI was necessary for such loss of interaction.
We have previously reported that at least two factor preparations, eIF-2 and Co-eIF-2B, are necessary for AUG-dependent Met-tRNAf binding to 40S ribosomes. The lack of interaction between eIF-2(P) and Co-eIF-2B could possibly explain
HRI inhibition of Met-tRNAf binding to 40S ribosomes, in
agreement with our previous hypothesis regarding the mechanism of HRI inhibition.
We also investigated the possibility that HRI may inhibit
more than one step in peptide chain initiation reactions (21).
We studied the effects of addition of HRI and ATP on the initial
formation of Met-tRNAf.40S-AUG complex and also on the
subsequent joining step using preformed Met-tRNAf.40S.AUG
with the 608 ribosomal subunit. As expected, HRI strongly inhibited Met-tRNAf.405 AUG complex formation in the presence of ATP (Table 2). However, HRI and ATP had no significant effect on the subsequent joining of preformed MettRNAf.408-AUG with 60S ribosomes to form the 80S initiation
complex.

Table 1. Effects of addition of Co-eIF-2A, Co-eIF-2B, and CoeIF-2C on Met-tRNAf binding to eIF-2 and eIF-2(P)
[35S]Met-tRNAf bound, pmol
+ Mg2+
No Mg2+
Factors added
Co-eIF-2A (Exp. 1)
0.50
eIF-2
1.25
eIF-2 + Co-eIF-2A
0.45
eIF-2(P)
1.20
eIF-2(P) + Co-eIF-2A

/

~~+eIF-2

20
0

C,,

/5-

Co-eIF-2B (Exp. 2)
1.35
eIF-2
1.70
eIF-2 + Co-eIF-2B
1.66
eIF-2(P)
1.55
eIF-2(P) + Co-eIF-2B

1.40
0.52
1.50
1.45

Co-eIF-2C (Exp. 3)
1.70
2.03
1.54
1.58

0.60
1.70
0.57
0.59

eIF-2
eIF-2 + Co-eIF-2C
eIF-2(P)
eIF-2(P) + Co-eIF-2C

25-

In Exp. 1, a one-stage assay method was used. Amounts of eIF-2,
eIF-2(P), and Co-eIF-2A were 0.4,0.5, and 16 Mg, respectively. In Exp.
2, a two-stage assay method was used. In stage 1, 0.8 gg of eIF-2 or 1.0
*Ag of eIF-2(P) in the presence or absence of 7 ,Mg of Co-eIF-2B was
incubated as in Exp. 1 (no Mg2+). In stage 2, magnesium acetate was
added to make the system 5 mM in Mg2+; the same volume (5gl) of
water was added to duplicate tubes. The reaction mixtures were
chilled in ice for 15 min. Reactions were terminated by addition of 3
ml of cold wash buffer (or wash buffer containing 5 mM Mg2+ for the
tubes containing Mg2+). In Exp. 3, a one-stage assay method was used.
Amounts of eIF-2, eIF-2(P), and Co-eIF-2C were 0.8, 1.0, and 4 ,ug,
respectively. Where indicated, 1 mM Mg2+ was present in the reaction
mixture.

Cr

1

F-2-2P)
0+e

2

4

6
Co-e I F-2C, MI

8

10

FIG. 3. Effect of HRI on Co-eIF-2C-dependent stimulation of
ternary complex formation by eIF-2 and eIF-2(P). 0, with HRI; *,
without HRI. The standard two-stage Millipore filtration assay was
used. In stage 1, the reaction mixtures (total volume, 0.05 ml) contained: 30 mM Tris.HCl at pH 7.8,130 mM KCl, 10 ,ug of bovine serum
albumin, 3 mM dithiothreitol, 1.5 mM magnesium acetate, 0.2 mM
ATP, and 0.8 ug of eIF-2 or 1.0 jg of eIF-2(P) and Co-eIF-2C (protein
concentration, 0.8 mg/ml). The reaction mixtures were incubated at
37°C for 5 min. In stage 2, the reaction mixtures were mixed with 0.01
ml of GTP (final concentration, 0.26 mM) and 0.015 ml of [35S]MettRNAf (8-10 pmol) and were incubated for another 5 min at 37°C. The
reactions were terminated by addition of 3 ml of cold wash buffer.
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Table 2. Effects of addition of HRI and ATP on [35S]MettRNAr4OS-AUG complex formation and joining of preformed
[35SJMet-tRNAr40S-AUG with 60S ribosomal particle to form
[35S]Met-tRNAr80S-AUG complex
Radioactivity, cpm
Exp. 2
Exp. 1
80S region
40S region
Additions
890
2,740
None
7097
12,850
AUG
6069
12,010
HRI + AUG
6706
10,920
ATP + AUG
6034
3,520
HRI + ATP + AUG
40S and 80S initiation complexes were assayed by using the sucrose
density gradient centrifugation method (23). 40S initiation complex
formation: The reaction mixtures (0.075 ml) in stage 1 contained: 20
mM Tris.HCl at pH 7.8, 100 mM KCl, 2 mM dithiothreitol, 10 jg of
bovine serum albumin, 1 mM Mg2+, 20 lg of fraction II initiation
factors, and, where indicated, 0.5 Ag of HRI and 0.2 mM ATP. The
reaction mixtures were incubated at 370C for 5 min. The reaction
mixtures were placed in an ice bath and 0.26 mM GTP, 0.04 A280 unit
of AUG, 0.16 A260 unit of 40S ribosomes, and 10-12 pmol of [35SJ_
Met-tRNAf were added. At this stage, the volume of the reaction
mixture was 0.14 ml and the composition was adjusted to 20 mM
Tris-HCl at pH 7.8, 100 mM KCl, 2 mM dithiothreitol, and 2 mM
Mg2+. The reaction mixtures were incubated for an additional 5 min
at 37°C. Then additional Mg2+ (0.01 ml) was added to make the final
Mg2+ concentration 5 mM. After the mixture was incubated for an
additional 10 min at 0°C, 0.1 ml was layered on top of a 14-27% linear
sucrose density gradient (containing 20 mM Tris-HCl at pH 7.8, 100
mM KCI, 5 mM Mg2+, and 2 mM dithiothreitol) and centrifuged at
45,000 rpm for 90 min in an SW 50.1 rotor. The gradients were fractionated by using an ISCO density gradient fractionator, and 7-drop
fractions were collected into 3 ml of cold wash buffer containing 5 mM
Mg2+. The samples were filtered through Millipore filters; the filters
were washed twice with 10 ml of the same buffer, dried, and assayed
for radioactivity. 80S initiation complex formation: Formation was
carried out in four stages. In stage I, the 40S ribosome complex was
formed; The reaction mixture (total volume, 0.125 ml) contained 24
mM Tris-HCl at pH 7.8, 100 mM KCl, 10 ug of albumin, 2.4 mM dithiothreitol, 2 mM Mg2+, 0.26 mM GTP, 0.16 A260 unit of 40S ribosomes, 20 ,g of fraction II initiation factor, 10-12 pmol of [35S]MettRNAf, and 0.04 A2mo unit of AUG where indicated. The reaction
mixture was incubated at 37°C for 5 min. In stage II, 0.5 ug of HRI
and 0.2 mM ATP were added where indicated and the reaction mixtures were incubated at 37°C for 5 min. In stage III, 0.32 A260 unit of
60S ribosome was added and incubated for another 5 min at 37°C. In
stage IV, additional Mg2+ was added to adjust the final Mg2+ concentration to 5 mM and the reaction mixtures were incubated in ice
for 10 min. A 0.1-ml aliquot of this reaction mixture was layered on
top of a sucrose density gradient and analyzed as described for the
40S complex formation assay.

DISCUSSION
The results presented in this paper define the precise locus of
HRI inhibition. HRI phosphorylates the 38,000-dalton subunit
of eIF-2. In this work, we provide evidence that eIF-2(P) does
not interact with two other factors, Co-eIF-2B and Co-eIF-2C,
and the further presence of HRI or additional phosphorylation
of HRI or any other component(s) is not necessary for this loss
of interaction.
Also, our results using partial initiation reactions and artificial
mRNA (AUG codon) strongly suggest that HRI inhibition is
limited to phosphorylation and subsequent inactivation of eIF-2
and that HRI has no further inhibitory effect on any other step
in peptide chain initiation. Addition of HRI and ATP did not
have any effect on the subsequent joining of preformed MettRNAf-40S'AUG with 60S ribosomes to form the Met-tRNAf80S-AUG complex.
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